
VolitionRx Limited VNRX
€ 2.34
8.8%
Quartalsbericht 2026-Q1
hinzugefügt 14.05.2026
VolitionRx Limited Langfristiger Schuldenstrom 2011-2026 | VNRX
Langfristiger Schuldenstrom Jährlich VolitionRx Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 250 K | 222 K | 199 K | 245 K | 171 K | 180 K | 257 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 257 K | 171 K | 218 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 20.41 | 1.9 % | $ 592 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 17.34 | 5.67 % | $ 524 M | ||
|
Guardant Health
GH
|
27.7 M | $ 118.55 | 3.11 % | $ 14.9 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 115.14 | 0.04 % | $ 9.5 B | ||
|
Illumina
ILMN
|
79 M | $ 144.35 | 1.71 % | $ 23 B | ||
|
Celcuity
CELC
|
54 K | $ 141.62 | 0.91 % | $ 6.62 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 3.88 | 62.44 % | $ 5.16 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 21.66 | 2.39 % | $ 1.15 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 94.6 | -1.56 % | $ 6.38 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.8 | - | $ 7.96 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 424.51 | 0.63 % | $ 12.2 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 086.52 | 0.31 % | $ 22.4 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Natera
NTRA
|
7.64 M | $ 204.45 | -0.23 % | $ 20.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Personalis
PSNL
|
6.89 M | $ 8.3 | 4.4 % | $ 741 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 159.56 | 2.22 % | $ 7.91 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.96 | 0.67 % | $ 1.15 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
451 K | $ 19.06 | -1.04 % | $ 427 M | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 3.81 | -0.13 % | $ 353 M | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 448.97 | -0.59 % | $ 169 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.16 | 1.61 % | $ 25.8 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 55.04 | 2.57 % | $ 3.29 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 5.96 | 4.38 % | $ 249 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.41 | 2.55 % | $ 5.54 M | ||
|
Waters Corporation
WAT
|
31.1 M | $ 339.58 | -0.48 % | $ 20.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 254.26 | -1.19 % | $ 21.2 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Exagen
XGN
|
1.23 M | $ 4.06 | 6.01 % | $ 87.5 M | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 8.77 | -0.68 % | $ 1.9 B |